Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180426 | SCV000232859 | uncertain significance | not provided | 2015-04-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000642705 | SCV000764392 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-05-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg8494*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). ClinVar contains an entry for this variant (Variation ID: 198960). This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive TTN-related conditions and/or TTN-related conditions (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). |
Ai |
RCV000180426 | SCV002501777 | uncertain significance | not provided | 2021-07-23 | criteria provided, single submitter | clinical testing |